An Update on Psychopharmacological Treatment of Autism Spectrum Disorder.

ABSTRACT: While behavioral interventions remain the mainstay of treatment of autism spectrum disorder (ASD), several potential targeted treatments addressing the underlying neurophysiology of ASD have emerged in the last few years. These are promising for the potential to, in future, become part of the mainstay treatment in addressing the core symptoms of ASD. Although it is likely that the development of future targeted treatments will be influenced by the underlying heterogeneity in etiology, associated genetic mechanisms influencing ASD are likely to be the first targets of treatments and even gene therapy in the future for ASD. In this article, we provide a review of current psychopharmacological treatment in ASD including those used to address common comorbidities of the condition and upcoming

SUBMITTER: Aishworiya R 

PROVIDER: S-EPMC9130393 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature